PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.90%
Revenue growth above 1.5x EXP's 5.61%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-67.09%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-93.13%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-93.13%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
13.90%
Positive net income growth while EXP is negative. John Neff might see a big relative performance advantage.
8.33%
Positive EPS growth while EXP is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
8.33%
Positive diluted EPS growth while EXP is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.01%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.05%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
187.25%
10Y revenue/share CAGR at 50-75% of EXP's 299.75%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
60.19%
5Y revenue/share CAGR at 50-75% of EXP's 94.29%. Martin Whitman would worry about a lagging mid-term growth trajectory.
16.73%
3Y revenue/share CAGR at 75-90% of EXP's 20.82%. Bill Ackman would expect new product strategies to close the gap.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
165.62%
Below 50% of EXP's 693.95%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
32.81%
5Y net income/share CAGR above 1.5x EXP's 7.82%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-36.76%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
63.54%
3Y equity/share CAGR 1.25-1.5x EXP's 53.65%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.